期刊文献+
共找到93篇文章
< 1 2 5 >
每页显示 20 50 100
Effective components of Chinese herbs reduce central nervous system function decline induced by iron overload 被引量:14
1
作者 Xian-hui Dong Jiang-tao Bai +7 位作者 Wei-na Kong Xiao-ping He Peng Yan Tie-mei Shao Wen-guo Yu Xi-qing Chai Yan-hua Wu Cong Liu 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第5期778-785,共8页
Abnormally increased levels of iron in the brain trigger cascade amplification in Alzheimer's dis- ease patients, resulting in neuronal death. This study investigated whether components extracted from the Chinese her... Abnormally increased levels of iron in the brain trigger cascade amplification in Alzheimer's dis- ease patients, resulting in neuronal death. This study investigated whether components extracted from the Chinese herbs epimedium herb, milkvetch root and kudzuvine root could relieve the abnormal expression of iron metabolism-related protein in Alzheimer's disease patients. An APPs,~JPSI^E9 double transgenic mouse model of Alzheimer's disease was used. The intragas- tric administration of compounds from epimedium herb, milkvetch root and kudzuvine root improved pathological alterations such as neuronal edema, increased the number of neurons, downregulated divalent metal transporter 1 expression, upregulated ferroportin 1 expression, and inhibited iron overload in the cerebral cortex of mice with Alzheimer's disease. These com- pounds reduced iron overload-induced impairment of the central nervous system, indicating a new strategy for developing novel drugs for the treatment of Alzheimer's disease. 展开更多
关键词 nerve regeneration neurodegenerative diseases Alzheimer's disease transgenic animalmodels mice epimedium herb milkvetch root kudzuvine root divalent metal transporter 1 ferroportin 1 neural regeneration
下载PDF
膜铁转运蛋白Ferroportin1的研究进展 被引量:11
2
作者 李静 钱忠明 +1 位作者 常彦忠 段相林 《生理科学进展》 CAS CSCD 北大核心 2004年第4期349-351,共3页
膜铁转运蛋白Ferroportin 1(2 0 0 0年发现 )在细胞铁的输出中起重要作用。它在成熟的十二指肠绒毛上皮细胞基底面、脾和肝的巨噬细胞、胎盘的合体滋养层细胞等都有表达。经序列分析显示Ferroportin 1具有十个跨膜结构域、一个还原酶位... 膜铁转运蛋白Ferroportin 1(2 0 0 0年发现 )在细胞铁的输出中起重要作用。它在成熟的十二指肠绒毛上皮细胞基底面、脾和肝的巨噬细胞、胎盘的合体滋养层细胞等都有表达。经序列分析显示Ferroportin 1具有十个跨膜结构域、一个还原酶位点和一个基底定位信号位点。此外 ,Ferroportin1mRNA转录在 5’非翻译区包含一个铁反应元件。本文对Ferroportin 1的目前研究进行了综述 ,并阐述了其医学应用前景。 展开更多
关键词 ferroportin 1 铁的输出
下载PDF
Role of alcohol in the regulation of iron metabolism 被引量:10
3
作者 Duygu Dee Harrison-Findik 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第37期4924-4930,共7页
Patients with alcoholic liver disease frequently exhibit increased body iron stores, as reflected by elevated serum iron indices (transferrin saturation, ferritin) and hepatic iron concentration. Even mild to moderate... Patients with alcoholic liver disease frequently exhibit increased body iron stores, as reflected by elevated serum iron indices (transferrin saturation, ferritin) and hepatic iron concentration. Even mild to moderate alcohol consumption has been shown to increase the prevalence of iron overload. Moreover, increased hepatic iron content is associated with greater mortality from alcoholic cirrhosis, suggesting a pathogenic role for iron in alcoholic liver disease. Alcohol increases the severity of disease in patients with genetic hemochromatosis, an iron overload disorder common in the Caucasian population. Both iron and alcohol individually cause oxidative stress and lipid peroxidation, which culminates in liver injury. Despite these observations, the underlying mechanisms of iron accumulation and the source of the excess iron observed in alcoholic liver disease remain unclear. Over the last decade, several novel iron-regulatory proteins have been identified and these have greatly enhanced our understanding of iron metabolism. For example, hepcidin, a circulatory antimicrobial peptide synthesized by the hepatocytes of the liver is now known to play a central role in the regulation of iron homeostasis. This review attempts to describe the interaction of alcohol and iron-regulatory molecules. Understanding these molecular mechanisms is of considerable clinical importance because both alcoholic liver disease and genetic hemochromatosis are common diseases, in which alcohol and iron appear to act synergistically to cause liver injury. 展开更多
关键词 Alcoholic liver disease C/EBP alpha Divalentmetal transporter 1 ferroportin HEPCIDIN
下载PDF
DL-3-n-butylphthalide alleviates motor disturbance by suppressing ferroptosis in a rat model of Parkinson’s disease 被引量:5
4
作者 Chun-Bo Hu Hui Jiang +5 位作者 Yin Yang Guo-Hua Wang Qiu-Hong Ji Zhong-Zheng Jia Li-Hua Shen Qian-Qian Luo 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第1期194-199,共6页
DL-3-n-butylphthalide(NBP)-a compound isolated from Apium graveolens seeds-is protective against brain ischemia via various mechanisms in humans and has been approved for treatment of acute ischemic stroke.NBP has sho... DL-3-n-butylphthalide(NBP)-a compound isolated from Apium graveolens seeds-is protective against brain ischemia via various mechanisms in humans and has been approved for treatment of acute ischemic stroke.NBP has shown recent potential as a treatment for Parkinson’s disease.However,the underlying mechanism of action of NBP remains poorly understood.In this study,we established a rat model of Parkinson’s disease by intraperitoneal injection of rotenone for 28 successive days,followed by intragastric injection of NBP for 14-28 days.We found that NBP greatly alleviated rotenone-induced motor disturbance in the rat model of Parkinson’s disease,inhibited loss of dopaminergic neurons and aggregation ofα-synuclein,and reduced iron deposition in the substantia nigra and iron content in serum.These changes were achieved by alterations in the expression of the iron metabolism-related proteins transferrin receptor,ferritin light chain,and transferrin 1.NBP also inhibited oxidative stress in the substantia nigra and protected mitochondria in the rat model of Parkinson’s disease.Our findings suggest that NBP alleviates motor disturbance by inhibition of iron deposition,oxidative stress,and ferroptosis in the substantia nigra. 展开更多
关键词 cystine/glutamate antiporter solute carrier family 7 member 11 DL-3-n-butylphthalide ferritin light chain ferroportin 1 ferroptosis glutathione peroxidase 4 oxidative stress iron ROTENONE transferrin receptor
下载PDF
脑缺血大鼠海马CA2区转铁蛋白受体及膜铁转运蛋白的表达及脑泰方提取物干预研究 被引量:9
5
作者 廖君 夏兴 +5 位作者 石咏梅 易亚乔 王国佐 周瑜 苏浩 葛金文 《中华中医药杂志》 CAS CSCD 北大核心 2014年第5期1406-1411,共6页
目的:研究脑缺血大鼠海马CA2区转铁蛋白受体(TFR)和膜铁转运蛋白(Fpn)随时间表达,及益气活血中药脑泰方提取物(NTE)干预对TFR及Fpn表达的影响,阐明脑缺血后铁代谢失调导致神经元损伤的新机制及益气活血中药NTE治疗通过调节细胞内铁代谢... 目的:研究脑缺血大鼠海马CA2区转铁蛋白受体(TFR)和膜铁转运蛋白(Fpn)随时间表达,及益气活血中药脑泰方提取物(NTE)干预对TFR及Fpn表达的影响,阐明脑缺血后铁代谢失调导致神经元损伤的新机制及益气活血中药NTE治疗通过调节细胞内铁代谢达到抗脑缺血损伤的作用机制。方法:第一部分实验:随机将SD大鼠分为2h、6h、12h、24h、72h组,采用大脑中动脉栓塞法(MCAO)行大鼠局灶性脑缺血模型制备,分别在术后2、6、12、24、72h各时间点取海马,通过免疫组化及RT-PCR检测海马CA2区TFR、Fpn及TFR mRNA、FpnmRNA随时间表达。第二部分实验,随机将SD大鼠分为NTE低、中、高剂量组(3、9、27g/kg)、假手术组及模型组。各组大鼠预处理灌胃(ig)给药连续3d,每日1次,再行MCAO模型制备术,术后连续ig给药3d。术后第3天采用Zea Longa神经行为学评分标准记录大鼠的行为活动,尼氏染色观察海马CA2区神经元,免疫组化法及RT-PCR检测TFR、Fpn和TFR mRNA、Fpn mRNA表达。结果:12h、24h、72h组TFR表达明显增加(P<0.05),12h组Fpn的表达明显增加(P<0.05);NTE高剂量组神经行为学评分较模型组有显著降低(P<0.05);NTE高剂量组尼氏体多,胞核、胞仁较清晰显示;与模型组比较,NTE高剂量组TFR和TFR mRNA表达明显减少(P<0.05),与假手术组和模型组比较,NTE高剂量组Fpn和Fpn mRNA表达明显增高(P<0.05)。结论:铁调节失衡可能是导致脑缺血神经元损伤的新机制,脑缺血后NTE能通过干预大鼠海马CA2区TFR、Fpn的表达,调节神经元铁代谢,达到保护神经元,恢复神经功能的作用。 展开更多
关键词 转铁蛋白受体 膜铁转运蛋白 NTE提取物 脑缺血
原文传递
Baicalin suppresses iron accumulation after substantia nigra injury: relationship between iron concentration and transferrin expression 被引量:6
6
作者 Chunyan Guo Xin Chen Pei Xiong 《Neural Regeneration Research》 SCIE CAS CSCD 2014年第6期630-636,共7页
Previous studies have shown that baicalin prevented iron accumulation after substantia nigra injury, reduced divalent metal transporter 1 expression, and increased ferroportin 1 expression in the substantia nigra of r... Previous studies have shown that baicalin prevented iron accumulation after substantia nigra injury, reduced divalent metal transporter 1 expression, and increased ferroportin 1 expression in the substantia nigra of rotenone-induced Parkinson's disease rats. In the current study, we investigated the relationship between iron accumulation and transferrin expression in C6 cells, to explore the mechanisms of the inhibitory effect of baicalin on iron accumulation observed in Parkinson's disease rats. Iron content was detected using inductively coupled plasma-atomic emission spectroscopy. Results showed that iron content decreased 41% after blocking divalent metal transporter 1 and ferroportin 1 proteins. After treatment with ferric ammonium citrate of differing concentrations (10, 50, 100, 400 ktg/mL) in C6 glioma cells, cell survival rate and ferroportin 1 expression were negatively correlated with ferric ammonium citrate concentration, but divalent metal transporter 1 expression positively correlated with ferric ammonium citrate concentration. Baicalin or deferoxamine reduced divalent metal transporter 1 expression, but increased ferroportin 1 expression in the 100 μg/mL ferric ammonium citrate-loaded C6 cells. These results indicate that baicalin down-regulated iron concentration, which positively regulat- ed divalent metal transporter 1 expression and negatively regulated ferroportin 1 expression, and decreased iron accumulation in the substantia nigra. 展开更多
关键词 nerve regeneration Parkinson's disease iron BAICALIN divalent metal transporter 1 ferroportin 1 DEFEROXAMINE C6 cells the Scientific Research Common Program of Beijing MunicipalCommission of Education neural regeneration
下载PDF
Ceruloplasmin-ferroportin system of iron traffic in vertebrates 被引量:6
7
作者 Giovanni Musci Fabio Polticelli Maria Carmela Bonaccorsi di Patti 《World Journal of Biological Chemistry》 CAS 2014年第2期204-215,共12页
Safe trafficking of iron across the cell membrane is a delicate process that requires specific protein carriers. While many proteins involved in iron uptake by cells are known, only one cellular iron export protein ha... Safe trafficking of iron across the cell membrane is a delicate process that requires specific protein carriers. While many proteins involved in iron uptake by cells are known, only one cellular iron export protein has been identified in mammals: ferroportin(SLC40A1). Ceruloplasmin is a multicopper enzyme endowed with ferroxidase activity that is found as a soluble isoform in plasma or as a membrane-associated isoform in specific cell types. According to the currently accepted view, ferrous iron transported out of the cell by ferroportin would be safely oxidized by ceruloplasmin to facilitate loading on transferrin. Therefore, the ceruloplasminferroportin system represents the main pathway for cellular iron egress and it is responsible for physiological regulation of cellular iron levels. The most recent findings regarding the structural and functional features of ceruloplasmin and ferroportin and their relationship will be described in this review. 展开更多
关键词 IRON HOMEOSTASIS ferroportin CERULOPLASMIN HEMOCHROMATOSIS Copper
下载PDF
Disruption of iron homeostasis and resultant health effects upon exposure to various environmental pollutants:A critical review 被引量:4
8
作者 Wenli Guo Jie Zhang +2 位作者 Wenjun Li Ming Xu Sijin Liu 《Journal of Environmental Sciences》 SCIE EI CAS CSCD 2015年第8期155-164,共10页
Environmental pollution has become one of the greatest problems in the world, and the concerns about environmental pollutants released by human activities from agriculture and industrial production have been continuou... Environmental pollution has become one of the greatest problems in the world, and the concerns about environmental pollutants released by human activities from agriculture and industrial production have been continuously increasing. Although intense efforts have been made to understand the health effects of environmental pollutants, most studies have only focused on direct toxic effects and failed to simultaneously evaluate the long-term adaptive, compensatory and secondary impacts on health. Burgeoning evidence suggests that environmental pollutants may directly or indirectly give rise to disordered element homeostasis, such as for iron. It is crucially important to maintain concerted cellular and systemic iron metabolism. Otherwise, disordered iron metabolism would lead to cytotoxicity and increased risk for various diseases, including cancers. Thus, study on the effects of environmental pollutants upon iron homeostasis is urgently needed. In this review, we recapitulate the available findings on the direct or indirect impacts of environmental pollutants, including persistent organic pollutants(POPs), heavy metals and pesticides, on iron homeostasis and associated adverse health problems. In view of the unanswered questions, more efforts are warranted to investigate the disruptive effects of environmental pollutants on iron homeostasis and consequent toxicities. 展开更多
关键词 Persistent organic pollutants Heavy metals Organophosphate pesticides Iron homeostasis Iron diseases Hepcidin ferroportin
原文传递
Iron dysregulation in beta-thalassemia 被引量:4
9
作者 Kamonlak Leecharoenkiat Pathrapol Lithanatudom +1 位作者 Wannapa Sornjai Duncan R.Smith 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第11期1013-1021,共9页
Iron deficiency anemia and iron overload conditions affect more than one billion people worldwide.Iron homeostasis involves the regulation of cells that export iron into the plasma and cells that utilize or store iron... Iron deficiency anemia and iron overload conditions affect more than one billion people worldwide.Iron homeostasis involves the regulation of cells that export iron into the plasma and cells that utilize or store iron.The cellular iron balance in humans is primarily mediated by the hepcidin-ferroportin axis.Ferroportin is the sole cellular iron export protein,and its expression is regulated transcriptionally,post-transcriptionally and posttranslationally.Hepcidin,a hormone produced by liver cells,post-translationally regulates ferroportin expression on iron exporting cells by binding with ferroportin and promoting its internalization by endocytosis and subsequent degradation by lysosomes.Dysregulation of iron homeostasis leading to iron deposition in vital organs is the main cause of death in betathalassemia patients.Beta-thalassemia patients show marked hepcidin suppression,ineffective eiythropoiesis,anemia and iron overload.Beta-thalassemia is common in the Mediterranean region,Southeast Asia and the Indian subcontinent,and the focus of this review is to provide an update on the factors mediating hepcidin related iron dysregulation in beta-thalassemia disease.Understanding this process may pave the way for new treatments to ameliorate iron overloading and improve the long term prognosis of these patients. 展开更多
关键词 BETA-THALASSEMIA HEPCIDIN Iron overload ferroportin
下载PDF
肠癌组织铁调素和膜转铁蛋白的表达及其与临床病理特征、贫血的关系 被引量:6
10
作者 程旭 陆晔 +2 位作者 李蓉 严敏 潘湘涛 《中国临床研究》 CAS 2015年第3期286-289,共4页
目的探讨肠癌患者与铁代谢相关的铁调素、膜转铁蛋白(FPN)的表达特点及其与临床特征、贫血的相关性。方法选取2009年1月至2014年1月在苏州大学附属太仓医院手术切除的62例肠癌患者的病理标本,另选择15例肠癌患者的癌旁正常肠粘膜组织作... 目的探讨肠癌患者与铁代谢相关的铁调素、膜转铁蛋白(FPN)的表达特点及其与临床特征、贫血的相关性。方法选取2009年1月至2014年1月在苏州大学附属太仓医院手术切除的62例肠癌患者的病理标本,另选择15例肠癌患者的癌旁正常肠粘膜组织作为对照组。应用SABC免疫组化方法检测62例肠癌患者癌组织中的铁调素及FPN的表达情况,并分析它们之间的相关性及其与临床病理特征、贫血的关系。结果 (1)铁调素在正常肠黏膜组织中阳性表达率为20.0%,肠癌组织中阳性表达率为66.1%,差异有统计学意义(P<0.01);FPN在正常肠黏膜组织中阳性表达率为86.7%,肠癌组织中阳性表达率为64.5%,差异无统计学意义(P>0.05)。(2)铁调素的表达与肿瘤T分期有关(P<0.05),而与年龄、性别、淋巴结转移、远处转移均无关(P均>0.05);FPN的表达与T分期及淋巴结转移有关(P<0.05,P<0.01),而与年龄、性别、远处转移均无关(P均>0.05)。(3)贫血与铁调素及FPN的表达无相关性(r=0.08,-0.04;P均>0.05);铁调素与FPN表达呈负相关(r=-0.39,P<0.01)。结论肠癌组织中铁调素的表达与患者肿瘤分期有关,并与FPN表达呈负相关,FPN表达与肿瘤分期及淋巴结转移有关。联合检测铁调素及FPN可作为反映肠道肿瘤生物学行为的客观指标。肠道肿瘤患者术前贫血与肿瘤组织中铁调素及FPN的表达无关。 展开更多
关键词 铁调素 膜转铁蛋白 肠癌 贫血 TNM分期 淋巴结转移 远处转移
原文传递
铁死亡抑制剂通过保护膜铁转运蛋白减轻脓毒症相关急性肾损伤 被引量:2
11
作者 张楷齐 吴晶魁 +6 位作者 姜娜 林其圣 祝旭颖 李佳琳 邵兴华 杨渊婷 倪兆慧 《中国临床医学》 2023年第2期229-237,共9页
目的利用脂多糖(lipopolysaccharide,LPS)构建脓毒症体内外模型,探讨铁死亡抑制剂在脓毒症相关急性肾损伤(sepsis associated acute kidney injury,S-AKI)中的保护作用及可能机制。方法构建脓毒症小鼠模型,随机分为4组:对照组、LPS组、L... 目的利用脂多糖(lipopolysaccharide,LPS)构建脓毒症体内外模型,探讨铁死亡抑制剂在脓毒症相关急性肾损伤(sepsis associated acute kidney injury,S-AKI)中的保护作用及可能机制。方法构建脓毒症小鼠模型,随机分为4组:对照组、LPS组、LPS+铁死亡抑制剂1(Ferrostatin-1,Fer-1)组和LPS+铁死亡抑制剂2(Deferoxamine,DFO)组,每组3只小鼠。LPS组小鼠腹腔注射LPS(15 mg/kg),铁死亡抑制剂组分别在LPS注射前30 min腹腔注射Fer-1(5 mg/kg)和DFO(100 mg/kg)。24 h后留取小鼠血液和肾脏标本进行肾功能和铁死亡相关标志物检测。体外培养人肾小管上皮细胞(HK-2),检测100μg/mL LPS刺激后细胞活性和不稳定铁池、脂质过氧化变化情况。使用siRNA转染HK-2细胞敲低膜铁转运蛋白(ferroportin,FPN)后检测铁死亡标志物变化情况。结果与对照组相比,LPS组小鼠血肌酐、尿素氮明显升高,肾脏病理损伤加重,铁死亡标志物显著增加,而铁死亡抑制剂组可明显缓解LPS诱导的肾脏功能和病理损伤,减少铁死亡表征。同时,Western印迹法和免疫组化结果显示,LPS组体内外模型中FPN表达量均显著下调,使用siRNA沉默HK-2细胞FPN观察到铁死亡表征增加,说明FPN参与铁死亡损伤过程。qRT-PCR结果显示,FPN下调与肾脏铁调素水平升高相关。进一步检测发现LPS激活铁调素启动子IL-6/STAT3通路,而Fer-1与DFO可以抑制相关通路的激活,减少铁调素mRNA表达,避免FPN下调。结论LPS可诱导FPN下调介导的铁死亡损伤,铁死亡抑制剂可能通过抑制铁调素降解FPN在LPS诱导的S-AKI中发挥保护作用。 展开更多
关键词 铁死亡 脓毒症 急性肾损伤 膜铁转运蛋白 铁调素
下载PDF
Hydralazine represses Fpn ubiquitination to rescue injured neurons via competitive binding to UBA52
12
作者 Shengyou Li Xue Gao +12 位作者 Yi Zheng Yujie Yang Jianbo Gao Dan Geng Lingli Guo Teng Ma Yiming Hao Bin Wei Liangliang Huang Yitao Wei Bing Xia Zhuojing Luo Jinghui Huang 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2024年第1期86-99,共14页
A major impedance to neuronal regeneration after peripheral nerve injury (PNI) is the activation of various programmed cell death mechanisms in the dorsal root ganglion. Ferroptosis is a form of programmed cell death ... A major impedance to neuronal regeneration after peripheral nerve injury (PNI) is the activation of various programmed cell death mechanisms in the dorsal root ganglion. Ferroptosis is a form of programmed cell death distinguished by imbalance in iron and thiol metabolism, leading to lethal lipid peroxidation. However, the molecular mechanisms of ferroptosis in the context of PNI and nerve regeneration remain unclear. Ferroportin (Fpn), the only known mammalian nonheme iron export protein, plays a pivotal part in inhibiting ferroptosis by maintaining intracellular iron homeostasis. Here, we explored in vitro and in vivo the involvement of Fpn in neuronal ferroptosis. We first delineated that reactive oxygen species at the injury site induces neuronal ferroptosis by increasing intracellular iron via accelerated UBA52-driven ubiquitination and degradation of Fpn, and stimulation of lipid peroxidation. Early administration of the potent arterial vasodilator, hydralazine (HYD), decreases the ubiquitination of Fpn after PNI by binding to UBA52, leading to suppression of neuronal cell death and significant acceleration of axon regeneration and motor function recovery. HYD targeting of ferroptosis is a promising strategy for clinical management of PNI. 展开更多
关键词 Ferroptosis UBA52 ferroportin UBIQUITINATION HYDRALAZINE Peripheral nerve injury
下载PDF
川芎-赤芍药对及其有效成分抑制ox-LDL诱导的巨噬细胞泡沫化及铁调素的作用机制
13
作者 许贵鹏 韦凤妮 +3 位作者 陈启庭 林宝虹 陈利捷 张淼 《中西医结合心脑血管病杂志》 2024年第18期3311-3315,共5页
目的:观察川芎-赤芍药对及其有效成分能否减缓细胞泡沫化,并探讨其作用机制。方法:采用氧化型低密度脂蛋白(ox-LDL)诱导人单核细胞白血病(THP-1)细胞建立泡沫化模型,将川芎-赤芍药对及其有效成分分别作用于ox-LDL诱导的THP-1细胞。采用... 目的:观察川芎-赤芍药对及其有效成分能否减缓细胞泡沫化,并探讨其作用机制。方法:采用氧化型低密度脂蛋白(ox-LDL)诱导人单核细胞白血病(THP-1)细胞建立泡沫化模型,将川芎-赤芍药对及其有效成分分别作用于ox-LDL诱导的THP-1细胞。采用油红O染色分析细胞泡沫化程度,通过逆转录定量聚合酶链反应(RT-qPCR)检测铁代谢相关铁调素(Hep)、膜铁转运蛋白(FPN)、铁调素调节蛋白(HJV)、血色素沉着症基因(HFE)、转铁蛋白受体2(TfR2)mRNA表达情况。结果:油红O细胞染色后镜下可见,染色后的红色脂滴因川芎-赤芍药对及其有效成分干预而减少。与对照组比较,模型组Hep、FPN、HFE、TfR2 mRNA表达上升,HJV mRNA表达减少;与模型组比较,川芎-赤芍药对及其有效成分干预组抑制作用明显,差异均有统计学意义(P<0.05或P<0.01)。结论:川芎-赤芍药对及其有效成分可抑制ox-LDL诱导的THP-1源巨噬细胞泡沫化,作用机制与川芎-赤芍药对及其有效成分调节铁代谢相关基因表达有关。 展开更多
关键词 川芎-赤芍药对 巨噬细胞泡沫化 铁调素 川芎嗪 芍药苷 实验研究
下载PDF
膜铁转运蛋白在肾性贫血中的研究进展 被引量:6
14
作者 席悦 杜玄一 《中国血液净化》 CSCD 2021年第4期273-276,共4页
膜铁转运蛋白(ferroportin,Fpn)是目前唯一的铁转出蛋白,它在控制饮食中铁的吸收,巨噬细胞和其他细胞中铁的排出中起着重要作用。铁是机体不可缺少的物质,参与血红蛋白合成。一旦Fpn的表达发生障碍,必定会导致铁代谢紊乱,从而引起多种... 膜铁转运蛋白(ferroportin,Fpn)是目前唯一的铁转出蛋白,它在控制饮食中铁的吸收,巨噬细胞和其他细胞中铁的排出中起着重要作用。铁是机体不可缺少的物质,参与血红蛋白合成。一旦Fpn的表达发生障碍,必定会导致铁代谢紊乱,从而引起多种疾病的发生发展。当然也可引起红细胞生成减少,甚至引起和加重慢性肾脏病(chronic kidney disease,CKD)贫血。因此,Fpn在机体铁代谢中发挥着重要作用。本文就Fpn在肾性贫血中的研究进展作一综述。 展开更多
关键词 膜铁转运蛋白 慢性肾脏病 贫血 铁代谢
下载PDF
不同浓度铁离子对成骨细胞铁离子通道蛋白的影响 被引量:5
15
作者 何银锋 徐又佳 +3 位作者 赵国阳 张增利 肖莉 王爱东 《中国骨质疏松杂志》 CAS CSCD 北大核心 2012年第8期700-703,共4页
目的铁过载与骨代谢相关,在人成骨细胞(hFOB1.19)中,膜转铁蛋白(FPN1)、转铁蛋白受体(TfR)和二价金属转运蛋白1(DMT1)是细胞内铁离子进入和排除的重要通道蛋白;本研究用不同浓度铁离子干预成骨细胞培养,观察成骨细胞铁离子通道蛋白基因... 目的铁过载与骨代谢相关,在人成骨细胞(hFOB1.19)中,膜转铁蛋白(FPN1)、转铁蛋白受体(TfR)和二价金属转运蛋白1(DMT1)是细胞内铁离子进入和排除的重要通道蛋白;本研究用不同浓度铁离子干预成骨细胞培养,观察成骨细胞铁离子通道蛋白基因表达变化和相互联系,了解铁过载对相关通道蛋白的影响意义。方法人成骨细胞在34℃下进行体外培养,以不同浓度枸橼酸铁铵FAC(50μmol/L、100μmol/L、200μmol/L)干预成骨细胞培养,48小时后收集细胞,按不同干预组抽提总RNA,采用半定量RT-PCR法检测成骨细胞中TfR、DMT1、FPN1 mRNA的表达。结果①RT-PCR检测显示不同浓度FAC干预成骨细胞后,各组FPN1、TfR、DMT1 mRNA均有表达;②不同浓度组FPN1、TfR、DMT1 mRNA表达光密度比值不同,组间密度比值比较存在统计学意义(P<0.05);③培养环境铁离子浓度增高可以使得FPN1的mRNA表达上调,而TfR、DMT1的mRNA表达下调。结论成骨细胞的铁通道蛋白受环境铁离子影响,在一定范围内随着细胞外铁离子浓度增加,细胞膜铁离子进入通道功能下调、排除通道功能上调,说明铁过载对成骨细胞内铁离子水平有明显影响。 展开更多
关键词 人成骨细胞 铁离子 膜转铁蛋白 转铁蛋白受体 二价金属转运蛋白
下载PDF
铁过载在输血依赖性血液系统疾病的概述及进展 被引量:5
16
作者 暴苗 赵艳红 周晋 《临床血液学杂志》 CAS 2018年第3期394-398,共5页
铁元素是人体健康不可或缺的微量元素,在人体内有多种功能如合成和修复DNA、参与血红蛋白合成、氧化还原反应、细胞增殖以及线粒体能量代谢,并且是多种酶的辅助因子[1-2]。铁过载(iron overload,IO)或者铁缺乏可能会引起相应症状,有... 铁元素是人体健康不可或缺的微量元素,在人体内有多种功能如合成和修复DNA、参与血红蛋白合成、氧化还原反应、细胞增殖以及线粒体能量代谢,并且是多种酶的辅助因子[1-2]。铁过载(iron overload,IO)或者铁缺乏可能会引起相应症状,有时甚至影响某些疾病的进展。铁缺乏将导致缺铁性贫血,已被临床医生所认识。 展开更多
关键词 铁过载 铁调素 膜铁转运蛋白 肝铁浓度 心脏铁沉积 地拉罗司
原文传递
Copper Accumulates in Hemosiderins in Livers of Patients with Iron Overload Syndromes 被引量:2
17
作者 Yukiya Ono Masatoshi Ishigami +13 位作者 Kazuhiko Hayashi Shinya Wakusawa Hisao Hayashi Kotaro Kumagai Natsuko Morotomi Tetsuji Yamashita Miwa Kawanaka Minemori Watanabe Hiroaki Ozawa Mayumi Tai Hiroaki Miyajima Kentarou Yoshioka Yoshiki Hirooka Hidemi Goto 《Journal of Clinical and Translational Hepatology》 SCIE 2015年第2期85-92,共8页
In biology,redox reactions are essential and sometimes harmful,and therefore,iron metabolism is tightly regulated by cuproproteins.Since the state of copper in iron overload syndromes remains unclear,we investigated w... In biology,redox reactions are essential and sometimes harmful,and therefore,iron metabolism is tightly regulated by cuproproteins.Since the state of copper in iron overload syndromes remains unclear,we investigated whether copper metabolism is altered in these syndromes.Eleven patients with iron overload syndromes participated in this study.The clinical diagnoses were aceruloplasminemia (n=2),hemochromatosis (n=5),ferroportin disease (n=2),and receiving excess intravenous iron supplementation (n=2).Liver specimens were analyzed using a light microscope and transmission electron microscope equipped with an X-ray analyzer.In addition to a large amount of iron associated with oxygen and phosphorus,the iron-rich hemosiderins of hepatocytes and Kupffer cells contained small amounts of copper and sulfur,regardless of disease etiology.Two-dimensional imaging clearly showed that cuproproteins were distributed homogenously with iron complexes within hemosiderins.Copper stasis was unlikely in noncirrhotic patients.The enhanced induction of cuproproteins by excess iron may contribute to copper accumulation in hemosiderins.In conclusion,we have demonstrated that copper accumulates in hemosiderins in iron overload conditions,perhaps due to alterations in copper metabolism. 展开更多
关键词 Aceruloplasminemia Cuproprotein induction ferroportin disease HEMOCHROMATOSIS HEMOSIDERIN Iron copper interaction Iron overload syndromes
原文传递
铁泵蛋白Ferroportin生理功能及其调控机制研究进展 被引量:3
18
作者 李大航 徐杉 +3 位作者 蒋丽 苏韵星 闵军霞 王福俤 《生命科学》 CSCD 北大核心 2022年第7期754-777,共24页
铁泵蛋白(Ferroportin, FPN/SLC40A1)是目前哺乳动物中唯一已知的铁外排膜蛋白,在调控机体铁稳态代谢过程中发挥重要作用。近年,围绕FPN蛋白转运铁离子生理功能及其分子调控机制方面取得了令人瞩目的研究进展。FPN蛋白通过从细胞内向外... 铁泵蛋白(Ferroportin, FPN/SLC40A1)是目前哺乳动物中唯一已知的铁外排膜蛋白,在调控机体铁稳态代谢过程中发挥重要作用。近年,围绕FPN蛋白转运铁离子生理功能及其分子调控机制方面取得了令人瞩目的研究进展。FPN蛋白通过从细胞内向外转运Fe参与许多关键生理过程,如细胞代谢、细胞命运以及铁死亡(ferroptosis)等。铁调素(Hepcidin)作为肝脏分泌的多肽,通过与FPN蛋白结合导致FPN内化降解,从而抑制小肠铁吸收及巨噬细胞的铁再循环,因此,Hepcidin-FPN轴是机体系统性铁稳态调控的核心枢纽。然而,FPN的具体降解机制一直是铁代谢领域内的热点及难点。近期,本研究团队发现E3泛素连接酶RNF217介导FPN降解及其受TET1 (甲基胞嘧啶双加氧酶1)修饰调控铁稳态代谢的新机制。临床研究发现,携带FPN基因突变的个体出现不同临床表现的血色病。此外,有研究报道FPN在肝脏疾病、肠道疾病、心脏疾病、贫血及癌症中发挥重要作用,提示FPN或可成为防治这些疾病的关键靶点。本文系统综述了FPN在金属离子转运、疾病发生及分子调控机制等方面的国内外最新研究进展,并就未来研究方向进行了展望和讨论。 展开更多
关键词 铁泵蛋白 铁调素 离子转运 血色病
原文传递
铁调素在铁稳态中的作用及其靶向药物开发 被引量:4
19
作者 赵晋英 李艳伟 《邵阳学院学报(自然科学版)》 2018年第5期78-92,共15页
铁在生物体起重要作用,铁吸收、储存、转运过程均受到精密的调控。铁调素(hepcidin,Hepc)是由肝脏产生的肽类激素,可以下调铁输出蛋白——膜铁转运蛋白(ferroportin,FPN),从而抑制肠道铁吸收和储铁器官铁释放,负性调控铁稳态的平衡。除... 铁在生物体起重要作用,铁吸收、储存、转运过程均受到精密的调控。铁调素(hepcidin,Hepc)是由肝脏产生的肽类激素,可以下调铁输出蛋白——膜铁转运蛋白(ferroportin,FPN),从而抑制肠道铁吸收和储铁器官铁释放,负性调控铁稳态的平衡。除肝脏外,其他器官也可表达少量铁调素,铁调素的表达受铁储量、红细胞生成活性、炎症、缺氧、内质网应激、甾体类激素等调节。铁调素过少可引起铁过载类疾病,铁调素过多可导致铁利用障碍性贫血、炎症性贫血等疾病。目前以铁调素为靶点的药物开发已经成为铁代谢研究领域的焦点和热点问题,一系列铁调素激动剂或拮抗剂类药物已经从实验室进入临床测试。文中主要论述铁调素在机体铁稳态中的作用,以及以铁调素为靶点的药物开发所取得的进展。 展开更多
关键词 铁调素 膜铁转运蛋白 铁稳态 铁调素激动剂 铁调素拮抗剂
下载PDF
膜铁转运蛋白的缺失对破骨细胞分化的影响 被引量:4
20
作者 周剑 王磊 储彬 《安徽医科大学学报》 CAS 北大核心 2018年第12期1893-1897,共5页
目的探究在骨髓谱系细胞中特异性敲除膜铁转运蛋白(Fpn)对破骨细胞分化的影响。方法实验组为Fpn基因敲除小鼠,对照组为含Fpn基因的小鼠,分别对两组小鼠骨髓巨噬细胞进行培养并诱导其分化成破骨细胞,且分为巨噬细胞组、前体细胞组、破骨... 目的探究在骨髓谱系细胞中特异性敲除膜铁转运蛋白(Fpn)对破骨细胞分化的影响。方法实验组为Fpn基因敲除小鼠,对照组为含Fpn基因的小鼠,分别对两组小鼠骨髓巨噬细胞进行培养并诱导其分化成破骨细胞,且分为巨噬细胞组、前体细胞组、破骨细胞组。通过TRAc P染色、RT-PCR及Western blot等方法探讨Fpn的缺失对破骨细胞分化的影响。结果染色显示实验组中成熟破骨细胞的阳性表达强于对照组。实验组NFATc1、PGC-1β的mRNA表达量及CTSK、NFATc1、PGC-1β的蛋白表达量均高于对照组(P<0. 01)。结论在骨髓谱系细胞中膜铁转运蛋白的缺失会促进破骨细胞的形成。 展开更多
关键词 膜铁转运蛋白 破骨细胞 分化
下载PDF
上一页 1 2 5 下一页 到第
使用帮助 返回顶部